---
title: "Gangtong Medical (301515): Won the bid for the procurement project of Nanjing Jianye Urban Construction Group Co., Ltd., with a bid amount of 9.3001 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287311389.md"
description: "Gangtong Medical won the bid for the procurement project of Nanjing Jianye Urban Construction Group Co., Ltd., with an amount of 9.3001 million yuan. The operating income for 2024 is 754 million yuan, net profit is 14 million yuan, and return on equity is 1.10%. In the first half of 2025, the operating income is 265 million yuan, and net profit is -8 million yuan"
datetime: "2026-05-22T05:31:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287311389.md)
  - [en](https://longbridge.com/en/news/287311389.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287311389.md)
---

# Gangtong Medical (301515): Won the bid for the procurement project of Nanjing Jianye Urban Construction Group Co., Ltd., with a bid amount of 9.3001 million yuan

According to Tongbi Finance, data from Qichacha shows that based on the "Public Announcement of the Bidding Results for the Procurement of Medical Gas Systems and Related Services for the Second Phase Project of Nanjing Children's Hospital Hexi Campus," Sichuan Gangtong Medical Equipment Group Co., Ltd. announced on May 22, 2026, that it won the procurement project of Nanjing Jianye Urban Construction Group Co., Ltd., with a winning bid amount of 9.3001 million yuan.

Related listed company: Gangtong Medical (301515.SZ)

_Tongbi Finance Tip:_

_Gangtong Medical (301515.SZ) reported an operating income of 754 million yuan in 2024, with an operating income growth rate of -10.49%. The net profit attributable to the parent company was 14 million yuan, with a net profit growth rate of -82.64%, and a return on equity of 1.10%._

_In the first half of 2025, the company's operating income was 265 million yuan, with an operating income growth rate of -39.29%. The net profit attributable to the parent company was -8 million yuan, with a net profit growth rate of -154.53%._

_Currently, the company belongs to the healthcare industry, with main product types including medical auxiliary equipment and professional consulting services. The 2024 report shows that the main composition of its business is: medical clean equipment and systems: 65.42%; medical gas equipment and systems: 29.43%; sales of medical devices and other products: 3.01%; operation and maintenance services: 1.85%; other businesses: 0.3%._

### Related Stocks

- [301515.CN](https://longbridge.com/en/quote/301515.CN.md)

## Related News & Research

- [Healthcare and 2 other lagging sectors to buy](https://longbridge.com/en/news/288374241.md)
- [Ladakh records over 43% rise in tourist arrivals in 2026: Lieutenant Guv](https://longbridge.com/en/news/288926280.md)
- [LIVE MARKETS-AI at the bond desk, not in charge yet](https://longbridge.com/en/news/288739616.md)
- [15:15 ETSynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver](https://longbridge.com/en/news/288898050.md)
- [World Cup gives North American transit a chance to shine - or be booed](https://longbridge.com/en/news/288554132.md)